Skip to main content

Advertisement

SpringerLink
Log in

Benefit of tumor resection for recurrent glioblastoma

  • Clinical Study
  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Abstract

In the treatment of glioblastoma (GBM) the impact of radical tumor resection as first line therapy is beyond controversy. The significance of a second resection in case of tumor-recurrence remains unclear and is an issue of debate. Since GBMs always recur, it is important to determine whether or not patients will benefit from repeat surgery. We performed a retrospective analysis of our prospectively collected database and evaluated all re-resected patients with primary GBM who underwent second surgery during a 3 years period. All patients underwent early postoperative magnetic resonance imaging. We determined survival after re-resection with regard to possible prognostic factors using Kaplan–Meier estimates and Cox regression analyses. Forty patients were included in this study. Median age was 58 years and median KPS score was 80. Average tumor volume was 5.5 cm3. A radiologically confirmed complete resection was achieved in 29 patients (72.5 %). Median follow-up was 18.8 months, and median survival after re-resection was 13.5 months. Only complete removal of contrast enhancing tumor was significantly correlated with survival after re-resection according to multivariate analysis. There was a statistical trend for KPS score influencing survival. In contrast, time between first diagnosis and tumor-recurrence, tumor volume at recurrence, MGMT status and MSM score were not significantly correlated with survival after second surgery. In the event of tumor recurrence, patients in good clinical condition with recurrent GBM amenable to complete resection should thus not be withheld second surgery as a treatment option.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Albert FK, Forsting M, Sartor K, Adams HP, Kunze S (1994) Early postoperative magnetic resonance imaging after resection of malignant glioma: objective evaluation of residual tumor and its influence on regrowth and prognosis. Neurosurgery 34(1):45–60 (discussion 60–41)

    Article  PubMed  CAS  Google Scholar 

  2. Barbagallo GM, Jenkinson MD, Brodbelt AR (2008) ‘Recurrent’ glioblastoma multiforme, when should we reoperate? Br J Neurosurg 22(3):452–455. doi:10.1080/02688690802182256

    Article  PubMed  Google Scholar 

  3. Barker FG 2nd, Chang SM, Gutin PH, Malec MK, McDermott MW, Prados MD, Wilson CB (1998) Survival and functional status after resection of recurrent glioblastoma multiforme. Neurosurgery 42(4):709–720 (discussion 720-703)

    Article  PubMed  Google Scholar 

  4. Bloch O, Han SJ, Cha S, Sun MZ, Aghi MK, McDermott MW, Berger MS, Parsa AT (2012) Impact of extent of resection for recurrent glioblastoma on overall survival. J Neurosurg 117(6):1032–1038. doi:10.3171/2012.9.JNS12504

    Article  PubMed  Google Scholar 

  5. Chaichana KL, Zadnik P, Weingart JD, Olivi A, Gallia GL, Blakeley J, Lim M, Brem H, Quinones-Hinojosa A (2012) Multiple resections for patients with glioblastoma: prolonging survival. J Neurosurg. doi:10.3171/2012.9.JNS1277

    PubMed Central  PubMed  Google Scholar 

  6. Chang SM, Butowski NA, Sneed PK, Garner IV (2006) Standard treatment and experimental targeted drug therapy for recurrent glioblastoma multiforme. Neurosurg Focus 20(4):E4

    PubMed  Google Scholar 

  7. Chang SM, Parney IF, McDermott M, Barker FG 2nd, Schmidt MH, Huang W, Laws ER Jr, Lillehei KO, Bernstein M, Brem H, Sloan AE, Berger M (2003) Perioperative complications and neurological outcomes of first and second craniotomies among patients enrolled in the Glioma Outcome Project. J Neurosurg 98(6):1175–1181. doi:10.3171/jns.2003.98.6.1175

    Article  PubMed  Google Scholar 

  8. Combs SE, Gutwein S, Thilmann C, Huber P, Debus J, Schulz-Ertner D (2005) Stereotactically guided fractionated re-irradiation in recurrent glioblastoma multiforme. J Neurooncol 74(2):167–171. doi:10.1007/s11060-004-2463-y

    Article  PubMed  CAS  Google Scholar 

  9. De Bonis P, Fiorentino A, Anile C, Balducci M, Pompucci A, Chiesa S, Sica G, Lama G, Maira G, Mangiola A (2013) The impact of repeated surgery and adjuvant therapy on survival for patients with recurrent glioblastoma. Clin Neurol Neurosurg 115(7):883–886. doi:10.1016/j.clineuro.2012.08.030

    Article  PubMed  Google Scholar 

  10. Dützmann S, Gessler F, Bink A, Quick J, Franz K, Seifert V, Senft C (2012) Risk of ischemia in glioma surgery: comparison of first and repeat procedures. J Neurooncol 107(3):599–607. doi:10.1007/s11060-011-0784-1

    Article  PubMed  Google Scholar 

  11. Filippini G, Falcone C, Boiardi A, Broggi G, Bruzzone MG, Caldiroli D, Farina R, Farinotti M, Fariselli L, Finocchiaro G, Giombini S, Pollo B, Savoiardo M, Solero CL, Valsecchi MG (2008) Prognostic factors for survival in 676 consecutive patients with newly diagnosed primary glioblastoma. Neuro Oncol 10(1):79–87

    Article  PubMed Central  PubMed  Google Scholar 

  12. Gorlia T, Stupp R, Brandes AA, Rampling RR, Fumoleau P, Dittrich C, Campone MM, Twelves CC, Raymond E, Hegi ME, Lacombe D, van den Bent MJ (2012) New prognostic factors and calculators for outcome prediction in patients with recurrent glioblastoma: a pooled analysis of EORTC Brain Tumour Group phase I and II clinical trials. Eur J Cancer 48(8):1176–1184

    Article  PubMed  Google Scholar 

  13. Guyotat J, Signorelli F, Frappaz D, Madarassy G, Ricci AC, Bret P (2000) Is reoperation for recurrence of glioblastoma justified? Oncol Rep 7(4):899–904

    PubMed  CAS  Google Scholar 

  14. Helseth R, Helseth E, Johannesen TB, Langberg CW, Lote K, Ronning P, Scheie D, Vik A, Meling TR (2010) Overall survival, prognostic factors, and repeated surgery in a consecutive series of 516 patients with glioblastoma multiforme. Acta Neurol Scand 122(3):159–167. doi:10.1111/j.1600-0404.2010.01350.x

    Article  PubMed  CAS  Google Scholar 

  15. Hong B, Wiese B, Bremer M, Heissler HE, Heidenreich F, Krauss JK, Nakamura M (2012) Multiple microsurgical resections for repeated recurrence of glioblastoma multiforme. Am J Clin Oncol. doi:10.1097/COC.0b013e3182467bb1

    PubMed  Google Scholar 

  16. Ko AL, Fink KR, Stelzer KM, Silbergeld DL (2012) Safety and efficacy of concomitant chemotherapeutic wafers and iodine-125 seeds for recurrent glioblastoma. Surg Neurol Int 3:137

    Article  PubMed Central  PubMed  Google Scholar 

  17. Kuhnt D, Becker A, Ganslandt O, Bauer M, Buchfelder M, Nimsky C (2011) Correlation of the extent of tumor volume resection and patient survival in surgery of glioblastoma multiforme with high-field intraoperative MRI guidance. Neuro Oncol 13(12):1339–1348

    Article  PubMed Central  PubMed  Google Scholar 

  18. Mandl ES, Dirven CM, Buis DR, Postma TJ, Vandertop WP (2008) Repeated surgery for glioblastoma multiforme: only in combination with other salvage therapy. Surg Neurol 69(5):506. doi:10.1016/j.surneu.2007.03.043 (discussion 509)

    Article  PubMed  Google Scholar 

  19. McGirt MJ, Chaichana KL, Gathinji M, Attenello FJ, Than K, Olivi A, Weingart JD, Brem H, Quinones-Hinojosa AR (2009) Independent association of extent of resection with survival in patients with malignant brain astrocytoma. J Neurosurg 110(1):156–162. doi:10.3171/2008.4.17536

    Article  PubMed  Google Scholar 

  20. Nabavi A, Thurm H, Zountsas B, Pietsch T, Lanfermann H, Pichlmeier U, Mehdorn M (2009) Five-aminolevulinic acid for fluorescence-guided resection of recurrent malignant gliomas: a phase ii study. Neurosurgery 65(6):1070–1076 (discussion 1076–1077)

    Article  PubMed  Google Scholar 

  21. Park JK, Hodges T, Arko L, Shen M, Dello Iacono D, McNabb A, Olsen Bailey N, Kreisl TN, Iwamoto FM, Sul J, Auh S, Park GE, Fine HA, Black PM (2010) Scale to predict survival after surgery for recurrent glioblastoma multiforme. J Clin Oncol 28(24):3838–3843. doi:10.1200/JCO.2010.30.0582

    Article  PubMed Central  PubMed  Google Scholar 

  22. Pichlmeier U, Bink A, Schackert G, Stummer W (2008) Resection and survival in glioblastoma multiforme: an RTOG recursive partitioning analysis of ALA study patients. Neuro Oncol 10(6):1025–1034. doi:10.1215/15228517-2008-052

    Article  PubMed Central  PubMed  Google Scholar 

  23. Pinsker M, Lumenta C (2001) Experiences with reoperation on recurrent glioblastoma multiforme. Zentralbl Neurochir 62(2):43–47. doi:10.1055/s-2002-19477

    Article  PubMed  CAS  Google Scholar 

  24. Sanai N, Polley MY, McDermott MW, Parsa AT, Berger MS (2011) An extent of resection threshold for newly diagnosed glioblastomas. J Neurosurg 115(1):3–8. doi:10.3171/2011.2.JNS10998

    Article  PubMed  Google Scholar 

  25. Sawaya R, Hammoud M, Schoppa D, Hess KR, Wu SZ, Shi WM, Wildrick DM (1998) Neurosurgical outcomes in a modern series of 400 craniotomies for treatment of parenchymal tumors. Neurosurgery 42(5):1044–1055 (discussion 1055–1046)

    Article  PubMed  CAS  Google Scholar 

  26. Senft C, Bink A, Franz K, Vatter H, Gasser T, Seifert V (2011) Intraoperative MRI guidance and extent of resection in glioma surgery: a randomised, controlled trial. Lancet Oncol 12(11):997–1003. doi:10.1016/S1470-2045(11)70196-6

    Article  PubMed  Google Scholar 

  27. Senft C, Franz K, Ulrich CT, Bink A, Szelenyi A, Gasser T, Seifert V (2010) Low field intraoperative MRI-guided surgery of gliomas: a single center experience. Clin Neurol Neurosurg 112(3):237–243

    Article  PubMed  Google Scholar 

  28. Stark AM, van de Bergh J, Hedderich J, Mehdorn HM, Nabavi A (2012) Glioblastoma: clinical characteristics, prognostic factors and survival in 492 patients. Clin Neurol Neurosurg 114(7):840–845

    Article  PubMed  Google Scholar 

  29. Stummer W, Pichlmeier U, Meinel T, Wiestler OD, Zanella F, Reulen HJ (2006) Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. Lancet Oncol 7(5):392–401

    Article  PubMed  CAS  Google Scholar 

  30. Stummer W, Reulen HJ, Meinel T, Pichlmeier U, Schumacher W, Tonn JC, Rohde V, Oppel F, Turowski B, Woiciechowsky C, Franz K, Pietsch T (2008) Extent of resection and survival in glioblastoma multiforme: identification of and adjustment for bias. Neurosurgery 62(3):564–576. doi:10.1227/01.neu.0000317304.31579.17 (discussion 564-576)

    Article  PubMed  Google Scholar 

  31. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352(10):987–996. doi:10.1056/NEJMoa043330

    Article  PubMed  CAS  Google Scholar 

  32. Terasaki M, Ogo E, Fukushima S, Sakata K, Miyagi N, Abe T, Shigemori M (2007) Impact of combination therapy with repeat surgery and temozolomide for recurrent or progressive glioblastoma multiforme: a prospective trial. Surg Neurol 68(3):250–254. doi:10.1016/j.surneu.2006.11.042

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurosurgery, University Hospital Frankfurt, Goethe University, Frankfurt, Germany

    Johanna Quick, Florian Gessler, Stephan Dützmann, Lutz M. Weise, Kea Franz, Volker Seifert & Christian Senft

  2. Institute of Neuroradiology, University Hospital Frankfurt, Goethe University, Frankfurt, Germany

    Elke Hattingen

  3. Neurological Institute (Edinger-Institute), University Hospital Frankfurt, Goethe University, Frankfurt, Germany

    Patrick N. Harter

Authors
  1. Johanna Quick
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Florian Gessler
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Stephan Dützmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Elke Hattingen
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Patrick N. Harter
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Lutz M. Weise
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Kea Franz
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Volker Seifert
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Christian Senft
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Johanna Quick or Christian Senft.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Quick, J., Gessler, F., Dützmann, S. et al. Benefit of tumor resection for recurrent glioblastoma. J Neurooncol 117, 365–372 (2014). https://doi.org/10.1007/s11060-014-1397-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11060-014-1397-2

Keywords

Search

Navigation